The pharmaceutical company Jiangzhong Pharmaceutical (600750.SH) released its first-quarter financial results, with a net profit attributable to shareholders of 285 million yuan, a year-on-year increase of 5.91%.

The Zhitong Finance and Economics APP reported that Jiangzhong Pharmaceutical (600750.SH) released its first quarter report for 2025. The company's operating income in the first quarter was 1.184 billion yuan, a year-on-year decrease of 7.03%; net profit attributable to shareholders of the listed company was 285 million yuan, a year-on-year increase of 5.91%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 261 million yuan, a year-on-year decrease of 1.14%; basic earnings per share were 0.45 yuan/share.